WallStreetZenWallStreetZen

NASDAQ: KMDA
Kamada Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KMDA past earnings growth

How has KMDA's earnings growth performed historically?
Company
N/A
Industry
13.52%
Market
71.87%
KMDA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
KMDA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

KMDA past revenue growth

How has KMDA's revenue growth performed historically?
Company
10.19%
Industry
10.18%
Market
17.2%
KMDA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KMDA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KMDA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KMDA earnings and revenue history

Current Revenue
$142.5M
Current Earnings
$8.3M
Current Profit Margin
5.8%
KMDA's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

KMDA Return on Equity

Current Company
4%
Current Industry
15.4%
Current Market
188%
KMDA's Return on Equity (4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KMDA announces earnings.

KMDA Return on Assets

Current Company
2.5%
Current Industry
3.4%
KMDA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KMDA Return on Capital Employed

Current Company
3.19%
Current Industry
5.1%
KMDA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KMDA vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KMDA$142.52M$22.44M$8.28M+4.48%-20.93%
ORGO$433.14M$36.03M$4.95M+17.49%-90.86%
PROC$414.10M$75.58M$52.20M-61.31%-38.62%
AQST$50.58M$1.18M-$7.87M-5.59%N/A
ACB$199.23M-$66.17M-$106.90M+17.87%N/A
View Top Pharmaceutical Stocks

KMDA earnings dates

Next earnings date
May 22, 2024

Kamada Earnings & Revenue FAQ

What were KMDA's earnings last quarter?

On Invalid Date, Kamada (NASDAQ: KMDA) reported Q4 2023 earnings per share (EPS) of $0.10, up 42.86% year over year. Total Kamada earnings for the quarter were $5.06 million. In the same quarter last year, Kamada's earnings per share (EPS) was $0.07.

If you're new to stock investing, here's how to buy Kamada stock.

What was KMDA's earnings growth in the past year?

As of Q2 2024, Kamada's earnings has grown year over year. Kamada's earnings in the past year totalled $8.28 million.

What is KMDA's earnings date?

Kamada's earnings date is Invalid Date. Add KMDA to your watchlist to be reminded of KMDA's next earnings announcement.

What was KMDA's revenue last quarter?

On Invalid Date, Kamada (NASDAQ: KMDA) reported Q4 2023 revenue of $36.43 million up 19.82% year over year. In the same quarter last year, Kamada's revenue was $45.44 million.

What was KMDA's revenue growth in the past year?

As of Q2 2024, Kamada's revenue has grown 10.19% year over year. This is 0.01 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Kamada's revenue in the past year totalled $142.52 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.